v3.26.1
Note 11 - Share Based Compensation (Details Textual) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 29, 2026
Jul. 22, 2025
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Share-Based Payment Arrangement, Expense     $ 661,230 $ 497,296 $ 1,355,493 $ 557,627  
Restricted Stock Units (RSUs) [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)         9,648,655   507,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period (in shares)         924,379   1,780,931
Equity Incentive Plan 2023 [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares) 20,000,000 10,000,000          
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)     52,000,000   52,000,000    
Common Stock, Capital Shares Reserved for Future Issuance (in shares)     25,657,319   25,657,319    
The Plan [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)     0   0   0
The Plan [Member] | Share-Based Payment Arrangement, Employee [Member]              
Share-Based Payment Arrangement, Expense         $ 0 0  
The RSU Plan [Member] | Restricted Stock Units (RSUs) [Member]              
Share-Based Payment Arrangement, Expense     $ 661,230 $ 497,296 1,355,493 $ 557,627  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value         $ 0   $ 0
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted (in shares)         0 14,080,635  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)         9,648,655 200,000  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period (in shares)         924,379 255,220  
Proceeds from Issuance or Sale of Equity         $ 0 $ 0